Decision (EU) 2025/1649 of the European Parliament of 7 May 2025 on discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023
Date: 2025-05-07
Institutions: European Parliament
Subjects: European Monitoring Centre for Drugs and Drug Addiction, budgetary discharge, drug addiction, drug traffic, financial year, general budget (EU), psychotropic substance








L_202501649EN.000101.fmx.xml












Official Journal of the European Union


EN
L series













2025/1649


8.10.2025







            DECISION (EU) 2025/1649 OF THE EUROPEAN PARLIAMENT
         
of 7 May 2025
         
on discharge in respect of the implementation of the budget of the European Monitoring Centre for Drugs and Drug Addiction (now European Union Drugs Agency) for the financial year 2023


THE EUROPEAN PARLIAMENT,







—


having regard to the final annual accounts of the European Monitoring Centre for Drugs and Drug Addiction for the financial year 2023,










—


having regard to the Court of Auditors’ annual report on EU agencies for the financial year 2023, together with the agencies’ replies (1),










—


having regard to the statement of assurance (2) as to the reliability of the accounts and the legality and regularity of the underlying transactions provided by the Court of Auditors for the financial year 2023, pursuant to Article 287 of the Treaty on the Functioning of the European Union,










—


having regard to the Council’s recommendation of 17 February 2025 on discharge to be given to the Centre in respect of the implementation of the budget for the financial year 2023 (05755/2025 – C10-0024/2025),










—


having regard to Article 319 of the Treaty on the Functioning of the European Union,










—


having regard to Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council of 18 July 2018 on the financial rules applicable to the general budget of the Union, amending Regulations (EU) No 1296/2013, (EU) No 1301/2013, (EU) No 1303/2013, (EU) No 1304/2013, (EU) No 1309/2013, (EU) No 1316/2013, (EU) No 223/2014, (EU) No 283/2014, and Decision No 541/2014/EU and repealing Regulation (EU, Euratom) No 966/2012 (3), and in particular Article 70 thereof,










—


having regard to Regulation (EU, Euratom) 2024/2509 of the European Parliament and of the Council of 23 September 2024 on the financial rules applicable to the general budget of the Union (4), and in particular Article 70 thereof,










—


having regard to Regulation (EC) No 1920/2006 of the European Parliament and of the Council of 12 December 2006 on the European Monitoring Centre for Drugs and Drug Addiction (5), and in particular Article 15 thereof,










—


having regard to Regulation (EU) 2023/1322 of the European Parliament and of the Council of 27 June 2023 on the European Union Drugs Agency (EUDA) and repealing Regulation (EC) No 1920/2006 (6), and in particular Article 41 thereof,










—


having regard to Commission Delegated Regulation (EU) 2019/715 of 18 December 2018 on the framework financial regulation for the bodies set up under the TFEU and Euratom Treaty and referred to in Article 70 of Regulation (EU, Euratom) 2018/1046 of the European Parliament and of the Council (7), and in particular Article 105 thereof,










—


having regard to Rule 102 of and Annex V to its Rules of Procedure,










—


having regard to the opinions of the Committee on Employment and Social Affairs, the Committee on the Environment, Climate and Food Safety, the Committee on Transport and Tourism, the Committee on Fisheries, the Committee on Culture and Education, the Committee on Civil Liberties, Justice and Home Affairs, and the Committee on Women’s Rights and Gender Equality,










—


having regard to the report of the Committee on Budgetary Control (A10-0065/2025),













1.


Grants the Director of European Union Drugs Agency discharge in respect of the implementation of the Centre’s budget for the financial year 2023;










2.


Sets out its observations in the resolution below;










3.


Instructs its President to forward this decision, and the resolution forming an integral part of it, to the Director of European Union Drugs Agency, the Council, the Commission and the Court of Auditors, and to arrange for their publication in the Official Journal of the European Union (L series).









The President

Roberta METSOLA
            



The Secretary-General

Alessandro CHIOCCHETTI
            





(1)  
            OJ C, C/2024/6332, 24.10.2024, ELI: http://data.europa.eu/eli/C/2024/6332/oj.

(2)  
            OJ C, C/2024/6041, 10.10.2024, ELI: http://data.europa.eu/eli/C/2024/6041/oj.

(3)  
            OJ L 193, 30.7.2018, p. 1, ELI: http://data.europa.eu/eli/reg/2018/1046/oj.

(4)  
            OJ L, 2024/2509, 26.9.2024, ELI: http://data.europa.eu/eli/reg/2024/2509/oj.

(5)  
            OJ L 376, 27.12.2006, p. 1, ELI: http://data.europa.eu/eli/reg/2006/1920/oj.

(6)  
            OJ L 166, 30.6.2023, p. 6, ELI: http://data.europa.eu/eli/reg/2023/1322/oj.

(7)  
            OJ L 122, 10.5.2019, p. 1, ELI: http://data.europa.eu/eli/reg_del/2019/715/oj.


ELI: http://data.europa.eu/eli/dec/2025/1649/oj
ISSN 1977-0677 (electronic edition)